Day: March 12, 2024

– Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 – – Partner Programs Continue to Report Positive Clinical Data Utilizing SCS Microinjector® – – Strengthened Capital Position from Registered Direct Equity Offering and Recent SCS Microinjector License Agreement – – Management to Host Webcast and Conference Call Today at 4:30 P.M. ET – ALPHARETTA, Ga., March 12, 2024 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today reported financial results for the fourth quarter and year ended December 31, 2023, and provided a corporate update. “This is an exciting time for Clearside with substantial progress...

AUSTIN, Texas, March 12, 2024 (GLOBE NEWSWIRE) — Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or “the Company”), the leading provider of patented wayfinding and mobile engagement solutions for mobile that enables brands to engage, manage and monetize anyone anywhere, today announced financial results for the year ended December 31, 2023. “Our company today is dramatically stronger than the one we talked about in November,” said Mike Snavely, CEO of Phunware. “With management changes, a reduction in our cost structure and marked improvements to the balance sheet we’ve moved into executing on our vision. We have significant traction with existing and new accounts and a new vision of how we’re serving our markets. We’ll share our plans on the earnings call and beyond.” Full Year 2023 Financial ResultsNet revenues from continuing operations...

Completes Strategic Transformation into a Pure-Play Cloud Company Launches SoftBank Personal Cloud in Q4, Expanding Global Reach of Cloud Platform Q4 Revenue of $41.4 Million Includes Year-Over-Year Cloud Growth and Exceeds Expectations Company Reaffirms 2024 Guidance BRIDGEWATER, N.J., March 12, 2024 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in personal Cloud platforms, today reported financial results for its fourth quarter ended December 31, 2023. On October 31, 2023, the Company entered into an Asset Purchase Agreement to divest its Messaging and NetworkX businesses. As such, unless otherwise noted, all financial metrics herein represent continuing operations, except for the Consolidated Statements of Cash Flows, which are presented for the...

Release Includes Commentary on Early 2024 Progress SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its fourth quarter and full-year ended December 31, 2023. 2023 Full Year and Fourth Quarter HighlightsReported fourth quarter 2023 revenue of $6.8 million, a 32% year-over-year increase compared with the fourth quarter of 2022; Reported revenue of $24.0 million for the full year 2023, an increase of 17% over 2022 and representing the ninth consecutive year of growth; Increased biologics and drug delivery revenue to $13.6 million for the full year 2023, a 49% increase over 2022; Completed Certification of Carlsbad development...

ROCKVILLE, Md., March 12, 2024 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, today announced its fourth quarter and full year ended December 31, 2023 financial results and reiterated its 2024 guidance. Fourth Quarter and Full Year HighlightsTotal revenue of $15.7 million in the fourth quarter of 2023, an increase of 26% over the fourth quarter of 2022. Core business revenue of $7.2 million in the fourth quarter of 2023, a decline of 32% over the fourth quarter of 2022. Strategic Platform License (SPL) Program-related revenue was $8.5 million for the fourth quarter of 2023, an increase of 359%...

Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year Issues 2024 guidance with Insurance MCR range of 79% – 83% and up to $20 million of Adjusted EBITDA profitability at the high end of the range FRANKLIN, Tenn., March 12, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a managed care company focused on physician enablement, today reported financial results for the fourth quarter and full year 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights. For the fourth quarter 2023, the Company reported revenue...

– Fourth Quarter GAAP Net Income More Than Triples to $9 Million, Adjusted EBITDA up 21% to $9.7 Million – LEHI, Utah, March 12, 2024 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a leading natural health and wellness company of premium-quality herbal and nutritional products, reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights vs. Same Year-Ago QuarterNet sales were up 6.0% to $108.9 million compared to $102.7 million (up 5.6% in constant currency). GAAP net income attributable to common shareholders up significantly to $9.0 million, or $0.46 per diluted share, compared to $2.0 million, or $0.10 per diluted share. Adjusted EBITDA up 21% to $9.7 million compared to $8.0 million.Full...

Full Year Total Revenue Grew 14% to $18.2 Million, Marking Highest Level Since 2016 Annual Recurring Revenue (ARR) increased 23% to Record $12 Million, Exceeding Total Revenue Reported at Beginning of Transformation in FY 2020 BURLINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data science, machine learning, and artificial intelligence to tackle everyday business and identity challenges through biometrics, today reported financial results for the fourth quarter and fiscal year ended December 31, 2023. Full Year 2023 Financial HighlightsTotal revenue increased 14% to $18.2 million from $16.0 million in 2022, representing the highest level of total revenue since 2016. Annual Recurring Revenue (ARR) increased 23% to an all-time high of $12.0 million, compared...

Company Delivers Record Financial Results with EBITDA of $22.3 Million2023 Revenue of $137.1 million 2023 Net income of $20.6 million 2023 $22.3 million EBITDA 2023 EPS of $1.39 Gross profit margin increased to 26%BARTLETT, Tenn., March 12, 2024 (GLOBE NEWSWIRE) — SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecom company focused on the underbanked and underserved, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Full Year 2023 and Fourth Quarter HighlightsRevenue of $137.1 million for the full year 2023 and $32.3 million for the fourth quarter, changes of 13% and -11% over the prior year periods, respectively. Gross profit of $35.6 million for the full year 2023 and $7.4 million for the fourth quarter, increases of 165% and 11% over...

Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear ending cash balance of $21.7M NASHUA, N.H., March 12, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, today announced results for its fiscal fourth quarter and full year ended December 31, 2023, as compared to the corresponding period of the last fiscal year. Fourth Quarter 2023 Financial Highlights:Total ARR was $8.7 million, up 15% Total revenues were $4.7 million, up 2% Gross Profit Margin % was 91%, up from 84% GAAP Net Loss from continuing operations ($0.5) million, improvement from ($2.3) million Operating...